Subanalysis of a prospective , @-month , multicenter , phase IIIb trial ( Efficacy and Safety of Ranibizumab in Patients with Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration -LSB- EXCITE -RSB- ) .